Science Paper | Engineering | 2024
Read Original Full Article at sciencedirect

Executive Brief

This review explores vanillin — a GRAS food additive widely used in baked goods, confectionery and infant formula — as a low-cost, inherently safe starting material for green pesticide development. With a price of USD 3–4/kg, vanillin’s simple structure featuring a reactive hydroxyl and aldehyde group enables efficient synthesis of antiviral and antibacterial derivatives via ether bond formation, thioacetalisation and reductive amination. Pioneering work by Song et al. has delivered compounds like vanisulfane with superior activity against plant viruses such as PVY, CMV, ToCV and TSWV, often outperforming commercial benchmarks like ribavirin and ningnanmycin. These derivatives primarily act as plant immune activators, boosting defensive enzymes (POD, PAL, SOD, CAT), ROS accumulation and SA/ABA signalling pathways, whilst some directly bind viral coat or nucleocapsid proteins to disrupt replication and assembly. Biosafety studies confirm rapid degradation and low mammalian toxicity, positioning vanillin-derived pesticides as a promising path for sustainable crop protection.

Keywords: Vanillin Pesticides, Green Pesticides, Plant Immune Activator, Vanisulfane, Antiviral Derivatives, Thioacetalisation, Biosafety.

Technical Intelligence

1. Core Technology / Process
Vanillin structural advantages: Hydroxyl group (–OH): Under basic conditions, forms a nucleophilic anion that reacts with electrophiles (alkyl halides) to create ether linkages, enabling splicing of bioactive moieties like thienopyrimidine, coumarin or mesoionic structures. Aldehyde group: Highly versatile for imine formation (reductive amination), thioacetalisation (with mercaptans) or β-cyclodextrin-SO3H catalysed annulation to imidazo[1,2-a]pyridin-3-amines.
Synthesis strategies: Two-step thioacetalisation (vanisulfane): Vanillin → etherified vanillin → thioacetal with ZrCl4 catalyst. Click chemistry for glycoside derivatives: Azide-functionalised glucose + vanillin alkyne → 1,2,3-triazole → thioacetalisation or deacetylation. Multi-step for mesoionic: Quinazoline ring closure → hydroxymethylation → chlorination → etherification → thioacetalisation.
Catalytic innovations: ZrCl4 for chemoselective thioacetalisation (protects hydroxyl). NaHSO4·SiO2 as economical ZrCl4 alternative.

 

2. Key Ingredients / Specifications
Lead compound: Vanisulfane (3a / “xiangcaoliusuobingmi”): Broad-spectrum antiviral against PVY, CMV, PMMoV, ToCV and TSWV. EC50 superior to ribavirin, NNM and dufulin.
Strobilurin hybrids (7b): β-methoxyacrylate replaces 4-chlorophenyl in vanisulfane; improved activity against PVY, CMV and TMV.
Glycoside derivatives (13c): Glucopyranoside via click chemistry; best anti-ToCV activity (EC50 < NNM/COS); Kd = 0.12 μmol·L⁻¹ to ToCV-CP (vs NNM 0.26 μmol·L⁻¹).
Quinazolinone derivatives (18c): EC50 = 188 μg·mL⁻¹ vs TSWV; superior to ribavirin (642 μg·mL⁻¹), vanisulfane (420 μg·mL⁻¹), NNM (257 μg·mL⁻¹).
Mesoionic pyrido[1,2-a]pyrimidinone derivatives: 28d: EC50 10.9 μg·mL⁻¹ (Xoo), 17.5 μg·mL⁻¹ (Xac); protective efficacy 43.9% (BLB), 41.7% (BLS).

3. Performance Data

Compound	Target	EC50 / Activity	Comparison
Vanisulfane	PVY/CMV	Superior to ribavirin/NNM/dufulin	Protective: 59.4% vs PMMoV (COS: 36.9%)
7b	PVY/CMV/TMV	Improved vs vanisulfane	–
13c	ToCV	Superior to NNM/COS/ribavirin	Kd = 0.12 μmol·L-1 to ToCV-CP
18c	TSWV	188 μg·mL-1	Ribavirin: 642 μg·mL-1
28d	Xoo/Xac	10.9/17.5 μg·mL-1	Bismerthiazol: 29.3/39.8 μg·mL-1

• Enzyme activation: Vanisulfane boosts POD, PAL, SOD, CAT; upregulates ROS, ABA; downregulates SA repressor ABR1.
• Gene/protein: Increases UspA, DEAD-box RNA helicase, POD52, APX, PR-1.
• Binding affinity: 13d Kd = 0.12 μmol·L⁻¹ (ToCV-CP); 29 Kd = 10.22 μmol·L⁻¹ (TSWV-N).

4. Market / Sustainability

• Cost/safety: USD 3–4/kg; FDA GRAS status (used in infant formula).
• Degradation: Rapid hydrolysis accelerated by Cu²⁺ and fulvic acid; forms thioether cleavage, reverse thioacetalisation, ether cleavage, demethylation, dehydration products.
• Metabolism (rats): 83.30%–87.51% excreted in 24h (urine/feces); liver/kidney accumulation; gender differences (males prefer biliary excretion); 8 metabolites identified via ¹⁴C labelling + LC–QTOF–MS.
• Perspective:
  • Aldehyde modification (aldol, Perkin, asymmetric catalysis).
  • Insecticide/herbicide pharmacophores (2-chlorothiazole, cyano, pyrimidinedione).
  • Solid chemistry (polymorphs, cocrystals, salts) for bioavailability.
  • Target identification (activity-based protein profiling, co-IP, Y2H).

Entity & Keyword Index

Category	Items
Lead Compounds	Vanisulfane (3a); 7b; 13c; 18c; 28d
Targets	PVY, CMV, PMMoV, ToCV, TSWV, Xoo, Xac, BLB, BLS
Mechanisms	Immune activation (ROS, SA/ABA pathways); CP/N-protein binding
Catalysts	ZrCl4, NaHSO4·SiO2, CuSO4·5H2O/ascorbate
Techniques	MST, RT-qPCR, Western blot, proteomics, LC–QTOF–MS

Disclaimer

This content is an independent analysis and structured summary of publicly available industry news, prepared solely for professional research, information exchange and educational purposes. It does not constitute endorsement, promotion or recommendation of any product, company, brand or technology mentioned herein.

All technical data, structures, mechanisms and bioassay results cited herein are extracted from the original article as published and have not been independently verified by us. Readers are advised to consult the original source for authoritative information.

Copyright of the original article by iScience. The copyright and all other rights in the original work reproduced here remain with the original author and/or publisher. Our company republishes this material strictly to facilitate professional information exchange and advance discussion of industry innovation, without any commercial exploitation or intent to infringe.

If you found this summary useful, kindly read and subscribe to the original publication at www.sciencedirect.com.